Vytrus Biotech, S.A. develops, produces, and sells active ingredients from plant stem cells for the cosmetic sector primarily in Spain. The company offers Nectaria Lithops, an active ingredient that biophysically optimizes the skin microenvironment and vitamin D levels; Photobiome a prebiotic active that stimulates the skin bacteria; Olea Vitae cellular oil for ageing; Turmeria Zen a natural active with regenerating properties for skin hydration and wrinkles on stressed profiles; Sensia Carota, a plant-based active that protects and prevents from the damage on sensitive and sensitized skins; Deobiome Noni, a prebiotic deodorant to reduces the generation of body odour; and Sarcoslim Re-Shape an active ingredient to reduce fat on tissue. It also offers Capilia Longa a natural active ingredient to improve density in hair, eyebrows, and eyelashes through a biological approach; Luminia Granatum for skin brightening, whitens dark spots, evens skin tone, and protection against oxidative stress; Elaya Renova a natural active that boosts hair tensegrity; Kannabia Sense a prebiotic treatment that stimulates the skin microbiota to produce an in-situ postbiotic cocktail; Quora Noni to avoid the attack of skin harmful bacteria; Quora Noni biomics for rejuvenating the skin microbiota; Centella Reversa for facial complexion improvement; and Arabian Cotton an active that provides photoprotection against UV, IR, and VIS radiation, and fights against photo-ageing. In addition, the company offers Baolift a novel skincare approach to enhance skin's molecular mechanisms and improve muscle tone and facial complexion; and Clarivine to activate skin’s regeneration processes. Further, it provides Vytrus TV to create an audiovisual space with added value for cosmetic formulation. Vytrus Biotech, S.A. was incorporated in 2009 and is based in Barcelona, Spain.
Spanish Market Performance
7D7 Days: -1.2%
3M3 Months: 3.4%
1Y1 Year: 25.2%
YTDYear to Date: 16.6%
The Financials sector gained 4.6% while the market remained flat over the last week. As for the longer term, the market has risen 25% in the past 12 months. Looking forward, earnings are forecast to grow by 5.6% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.